These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 39045646)

  • 21. Potential of stem cell therapy in intracerebral hemorrhage.
    Huang AP; Hsu YH; Wu MS; Tsai HH; Su CY; Ling TY; Hsu SH; Lai DM
    Mol Biol Rep; 2020 Jun; 47(6):4671-4680. PubMed ID: 32415506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concise Review: Is Cardiac Cell Therapy Dead? Embarrassing Trial Outcomes and New Directions for the Future.
    Tang JN; Cores J; Huang K; Cui XL; Luo L; Zhang JY; Li TS; Qian L; Cheng K
    Stem Cells Transl Med; 2018 Apr; 7(4):354-359. PubMed ID: 29468830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concise review: mind the gap: challenges in characterizing and quantifying cell- and tissue-based therapies for clinical translation.
    Rayment EA; Williams DJ
    Stem Cells; 2010 May; 28(5):996-1004. PubMed ID: 20333747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Professional regulation: a potentially valuable tool in responding to "stem cell tourism".
    Zarzeczny A; Caulfield T; Ogbogu U; Bell P; Crooks VA; Kamenova K; Master Z; Rachul C; Snyder J; Toews M; Zoeller S
    Stem Cell Reports; 2014 Sep; 3(3):379-84. PubMed ID: 25241736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Responding to requests of families for unproven interventions in neurodevelopmental disorders: hyperbaric oxygen "treatment" and stem cell "therapy" in cerebral palsy.
    Bell E; Wallace T; Chouinard I; Shevell M; Racine E
    Dev Disabil Res Rev; 2011; 17(1):19-26. PubMed ID: 22447751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products.
    Ikonomou L; Cuende N; Forte M; Grilley BJ; Levine AD; Munsie M; Rasko JEJ; Turner L; Bidkhori HR; Ciccocioppo R; Grignon F; Srivastava A; Weiss DJ; Zettler P; Levine BL;
    Cytotherapy; 2023 Sep; 25(9):920-929. PubMed ID: 37517865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stem cell tourism and public education: the missing elements.
    Master Z; Robertson K; Frederick D; Rachul C; Caulfield T
    Cell Stem Cell; 2014 Sep; 15(3):267-270. PubMed ID: 25192461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploiting science? A systematic analysis of complementary and alternative medicine clinic websites' marketing of stem cell therapies.
    Murdoch B; Zarzeczny A; Caulfield T
    BMJ Open; 2018 Feb; 8(2):e019414. PubMed ID: 29490963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reflection on the enactment and impact of safety laws for regenerative medicine in Japan.
    Takashima K; Morrison M; Minari J
    Stem Cell Reports; 2021 Jun; 16(6):1425-1434. PubMed ID: 34019814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proceedings: moving toward cell-based therapies for liver disease.
    Kadyk LC; Collins LR; Littman NJ; Millan MT
    Stem Cells Transl Med; 2015 Mar; 4(3):207-10. PubMed ID: 25637191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stem cell-based therapies in Parkinson's disease: future hope or current treatment option?
    Loewenbrück K; Storch A
    J Neurol; 2011 May; 258(Suppl 2):S346-53. PubMed ID: 21437664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concise review: cell therapies for hereditary metabolic liver diseases-concepts, clinical results, and future developments.
    Cantz T; Sharma AD; Ott M
    Stem Cells; 2015 Apr; 33(4):1055-62. PubMed ID: 25524146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From the margins to mainstream: How providers of autologous 'stem cell treatments' legitimise their practice in Australia.
    MacGregor C; Petersen A; Munsie M
    Health (London); 2021 Jan; 25(1):51-68. PubMed ID: 31081381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mapping and driving the stem cell ecosystem.
    Knoepfler PS
    Regen Med; 2018 Oct; 13(7):845-858. PubMed ID: 30289055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What's missing? Discussing stem cell translational research in educational information on stem cell "tourism".
    Master Z; Zarzeczny A; Rachul C; Caulfield T
    J Law Med Ethics; 2013; 41(1):254-68. PubMed ID: 23581669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem cell 'therapy' advertisements in China: Infodemic, regulations and recommendations.
    Lv J; Su Y; Song L; Gong X; Peng Y
    Cell Prolif; 2020 Dec; 53(12):e12937. PubMed ID: 33146925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinically relevant aspects of stem cell technologies: current state of play.
    Stuart MJ; Pattavilakom A
    ANZ J Surg; 2015 Sep; 85(9):615-9. PubMed ID: 25267417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promoting Brain Repair and Regeneration After Stroke: a Plea for Cell-Based Therapies.
    Dabrowski A; Robinson TJ; Felling RJ
    Curr Neurol Neurosci Rep; 2019 Feb; 19(1):5. PubMed ID: 30712068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stem cell-based treatment of kidney diseases.
    Pan B; Fan G
    Exp Biol Med (Maywood); 2020 May; 245(10):902-910. PubMed ID: 32281411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases 2017. An Official American Thoracic Society Workshop Report.
    Ryan AL; Ikonomou L; Atarod S; Bölükbas DA; Collins J; Freishtat R; Hawkins F; Gilpin SE; Uhl FE; Uriarte JJ; Weiss DJ; Wagner DE
    Am J Respir Cell Mol Biol; 2019 Oct; 61(4):429-439. PubMed ID: 31573338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.